Dr. Pizzolato is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1475 NW 12th Ave
Miami, FL 33136Phone+1 305-689-6500Fax+1 305-689-6565- Is this information wrong?
Summary
- Joseph Pizzolato, M.D., is a triple board-certified hematologist and oncologist at Sylvester Comprehensive Cancer Center. At Sylvester, Dr. Pizzolato works as part of a multidisciplinary team of cancer experts and researchers. He earned his medical degree from Icahn School of Medicine at Mount Sinai, New York.
Education & Training
University of MiamiMBA, Healthcare, 2020 - 2022
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2001 - 2004
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1998 - 2001
Icahn School of Medicine at Mount SinaiClass of 1998
Certifications & Licensure
FL State Medical License 2004 - 2026
NY State Medical License 1999 - 2007
NJ State Medical License 2001 - 2003
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- Phase II Trial of Abraxane and Capecitabine in Metastatic Colon Cancer (COL 01) Start of enrollment: 2007 Sep 01
Publications & Presentations
PubMed
- 6 citationsGenome-wide host methylation profiling of anal and cervical carcinoma.Erin M Siegel, Abidemi Ajidahun, Anders Berglund, Whitney Guerrero, Steven Eschrich, Ryan M Putney, Anthony Magliocco, Bridget Riggs, Kathryn Winter, Jeff P Simko, Jaf...> ;Plos One. 2021 Jan 1
- 6 citationsPhase II Trial of Combined Modality Therapy with Myeloid Growth Factor Support in Patients with Locally Advanced Non-small Cell Lung CancerRogerio Lilenbaum, Michael Samuels, Michele Taffaro-Neskey, Mike Cusnir, Joseph Pizzolato, Arnold Blaustein> ;Journal of Thoracic Oncology. 2010 Jun 1
- Phase II trial of combined modality therapy (cmt) with myeloid growth factors in patients with locally advanced non-small cell lung cancer (NSCLC).Lilenbaum R, Samuels M, Taffaro-Neskey M, Cusnir M, Pizzolato J, Blaustein A> ;J. Clin. Oncol.. 2008-05-20
- Join now to see all
Professional Memberships
- Member
Hospital Affiliations
UMHC - Sylvester ComprehensiveMiami, Florida
University of Miami HospitalMiami, Florida
UMHC-Sylvester Comprehensive Cancer CenterMiami, Florida
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
